Anti-myeloperoxidase antibodies in sera from patients with propylthiouracil-induced vasculitis might recognize restricted epitopes on myeloperoxidase molecule

Clinical and Experimental Immunology

Volumn 138, Issue 1, 2004, Pages 179-182

  Ye, H ^a   Zhao, Ming Hui ^a   Gao, Y ^a   Guo, X H ^a   Wang, H Y ^a  

^a PEKING UNIVERSITY FIRST HOSPITAL   (China)

Author keywords

Antibody; Epitope mapping; Microscopic polyangiitis propylthiouracil; Myeloperoxidase

Indexed keywords

ANTIBODY CONJUGATE; AUTOANTIBODY; EPITOPE; HORSERADISH PEROXIDASE; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 3D8; MONOCLONAL ANTIBODY 6B9; MYELOPEROXIDASE; MYELOPEROXIDASE ANTIBODY; NEUTROPHIL CYTOPLASMIC ANTIBODY; PAB1 HORSERADISH PEROXIDASE; PAB2 HORSERADISH PEROXIDASE; PROPYLTHIOURACIL; UNCLASSIFIED DRUG;

ADOLESCENT; ADULT; AFFINITY PURIFICATION; ANTIGEN RECOGNITION; ARTICLE; CLINICAL ARTICLE; COMPETITIVE INHIBITION; CONTROLLED STUDY; DRUG INDUCED DISEASE; ENZYME LINKED IMMUNOSORBENT ASSAY; EPITOPE MAPPING; FEMALE; HUMAN; MALE; PLASMAPHERESIS; PRIMARY MICROSCOPIC POLYANGIITIS; PRIORITY JOURNAL; PURIFICATION; SYSTEMIC VASCULITIS; VASCULITIS;

ADULT; ANTIBODIES, ANTINEUTROPHIL CYTOPLASMIC; ANTIBODIES, MONOCLONAL; ANTIBODY AFFINITY; ENZYME-LINKED IMMUNOSORBENT ASSAY; EPITOPES; FEMALE; HORSERADISH PEROXIDASE; HUMANS; MALE; MIDDLE AGED; PEROXIDASE; PROPYLTHIOURACIL; VASCULITIS;

EID: 4644338733     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1111/j.1365-2249.2004.02557.x     Document Type: Article

References (18)

1. Dolman KM, Gans RO, Rervaat TJ et al. Vasculitis and antineutrophil cytoplasmic autoantibodies associated with propylthiouracil therapy. Lancet 1993; 342:651-2.
2. Choi HK, Merkel PA, Walker AM, Niles JL. Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis: prevalence among patients with high titers of antimyeloperoxidase antibodies. Arthritis Rheum 2000; 43:405-13.
3. Gao Y, Zhao MH, Guo XH, Xin G, Gao Y, Wang HY. The prevalence and target antigens of antithyroid drugs induced antineutrophil cytoplasmic antibodies (ANCA) in Chinese patients with hyperthyroidism. Endocr Res 2004; 31:1-9.
4. Fujieda M, Hattori M, Kurayama H, Koitabashi Y. Clinical features and outcomes in children with antineutrophil cytoplasmic autoantibody-positive glomerulonephritis associated with propylthiouracil treatment. J Am Soc Nephrol 2002; 13:437-45.
5. Zhao MH, Lockwood CM. A comprehensive method to purify three major ANCA antigens: proteinase 3, myeloperoxidase and bactericidal/permeability-increasing protein from human neutrophil granule acid extract. J Immunol Meth 1996; 197:121-30.
6. Pharmacia LKB Biotechnology. Affinity chromatography principles and methods. Pharmacia LKB Biotechnology.
7. Claassen E. Immunocytochemical antigen-specific detection of antibodies. In: Lefkovits I, ed. Immunology methods manual. UK: Academic Press Limited, 1997:1051-2.
8. Short AK, Lockwood CM. Studies of epitope restriction on myeloperoxidase (MPO), an important antigen in systemic vasculitis. Clin Exp Immunol 1997; 110:270-6.
9. Falk RJ, Terrell RS, Charles LA, Jennette JC. Anti-neutrophil cytoplasmic autoantibodies induce nertrophils to degranulate and produce oxygen radicals in vitro. Proc Natl Acad Sci USA 1990; 87:4115-9.
10. Arimura Y, Minoshima S, Nakabayashi K et al. Serum myeloperoxidase and serum cytokines in antimyeloperoxidase antibody-associated glomerulonephritis. Clin Nephrol 1993; 40:256-64.
11. Jayne DR, Gaskin G, Pusey CD, Lockwood CM. ANCA and predicting relapse in systemic vasculitis. Q J Med 1995; 88:127-33.
12. Cohen P, Guillevin L, Baril L, Lhote F, Noel LH, Lesavre P. Persistence of antineutropil cytoplasmic antibodies (ANCA) in asymptomatic patients with systemic polyarteritis nodosa or Churg-Strauss syndrome: follow-up of 53 patients. Clin Exp Rheumatol 1995; 13:193-8.
13. Falk RJ, Becker M, Terrell R, Jennette JC. Anti-myeloperoxidase autoantibodies react with native but not denatured myeloperoxidase. Clin Exp Immunol 1992; 89:274-8.
14. Tomizawa K, Mine E, Fujii A et al. A panel set for epitope analysis of myeloperoxidase (MPO)-specific antineutrophil cytoplasmic antibody MPO-ANCA using recombinant hexamer histidine-tagged MPO deletion mutants. J Clin Immunol 1998; 18:142-52.
15. Audrain MA, Baranger TA, Moguilevski N et al. Anti-native and recombinant myeloperoxidase monoclonals and human autoantibodies. Clin Exp Immunol 1997; 107:127-34.
16. Fujii A, Tomizawa K, Arimura Y et al. Epitope analysis of myeloperoxidase (MPO) specific anti-neutrophil cytoplasmic autoantibodies (ANCA) in MPO-ANCA-associated glomerulonephritis. Clin Nephrol 2000; 53:242-52.
17. Lee E, Hirouchi M, Hosokawa M, Sayo H, Kohno M, Kariya K. Inactivation of peroxidases of rat bone marrow by repeated administration of propylthiouracil is accompanied by a change in the heme structure. Biochem Pharmacol 1988; 37:2151-3.
18. Jiang X, Khursigara G, Rubin RL. Transformation of lupus-inducing drugs to cytotoxic products by activated neutrophils. Science 1994; 266:810-3.